Dublin, Feb. 19, 2019 (GLOBE NEWSWIRE) -- The "3D-Culture, Organoids & Tox Screening Europe" conference has been added to ResearchAndMarkets.com's offering.
3D-Culture, Organoids & Tox Screening Europe 2019 brings together researchers from around the world focusing on the emerging technologies and applications of 3D-culture and organoids, especially as they are impacting drug discovery, toxicity screening and drug development processes.
Hear from and network with researchers who are currently screening for efficacy and toxicity using iPS cell lines (and cells derived thereof), and those responsible for developing the techniques and technologies in the organoids field. There will also be discussions on industry and regulatory developments that are shaping the future of 3D-culture and technologies for studying organoids in cancer research and beyond.
Topics to be covered include 3D-cell based screening methods, high content screening and data management, the use of model organisms and novel approaches for phenotypic screening.
Key Opinion Leaders from around the World are Participating at this Conference allowing Maximal Information Exchange and Unparalleled Networking Opportunities.
Agenda:
Day 1 - Thursday, 13 June 2019
08:00
Conference Registration, Materials Pick-Up, Morning Coffee and Pastries
08:50
Terry Riss - Conference Chair
- Chairman's Welcome and Introduction to the Conference
- Terry Riss, Global Strategic Marketing Manager Cell Health, Promega Corporation, United States of America
Session Title: Conference Opening Session
09:00
Gary Gintant - Keynote Presentation
- In vitro Safety Assays with Human Derived Cardiomyocytes. .Bridging the Translational Gap?
- Gary Gintant, Senior Research Fellow, Abbvie, United States of America
09:45
David Hay - Keynote Presentation
- Generating Human Liver Spheres From Pluripotent Stem Cells and Their Application
- David Hay, Chair of Tissue Engineering, MRC Centre for Regenerative Medicine, University of Edinburgh, United Kingdom
10:30
Morning Coffee Break and Networking in the Exhibit Hall
11:15
James Hickman - Keynote Presentation
- Title to be Confirmed.
- James Hickman, Professor, Nanoscience Technology, Chemistry, Biomolecular Science and Electrical Engineering, University of Central Florida; Chief Scientist, Hesperos, United States of America
12:00
- InSphero AGGoing 3D All the Way: 3D Microtissues in 384-well Plates and Modular Organ-on-a-Chip Solutions for Patient-Centric Drug Discovery
- Jan Lichtenberg, CEO & Co-Founder, InSphero AG
12:30
Networking Lunch in the Exhibit Hall and Poster Viewing
- Emerging Themes in Organoids and Organs-on-Chips: An Introduction
- Session Chair: Paul Vulto, Managing Director, MIMETAS, Netherlands
Session Title: Organoids and 3D-Culture - Technologies and Applications
14:00
- Phenotypic Screening in 3D Culture Including ECM: Advantages and Challenges
- Nathalie Maubon, CEO/CSO, HCS Pharma, France
- Grgory Maubon, Digital Coordinator, HCS Pharma, France
14:30
- Factors to Consider When Choosing a 3D Cell Culture Model System
- Terry Riss, Global Strategic Marketing Manager Cell Health, Promega Corporation, United States of America
15:00
- BrainSpheres to Study Developmental Neurotoxicity
- David Pamies, Researcher, University of Lausanne, Switzerland
15:30
Afternoon Coffee Break and Networking in the Exhibit Hall
16:00
- High Content Screening of Organoid Cultures to Visualize and Quantify Intestinal Toxicity
- Bram Herpers, COO, OcellO B V, Netherlands
16:30
- 3D Microtumor-based Combinatorial Drug Discovery
- Jens Kelm, CEO and Co-Founder, PreComb Therapeutics AG, Switzerland
17:00
Paul Vulto - Keynote Presentation
- Title to be Confirmed.
- Paul Vulto, Managing Director, MIMETAS, Netherlands
17:45
Networking Reception with Beer and Wine - Meet Colleagues and Network with New Acquaintances
18:45
Close of Day 1 of the Conference
Day 2 - Friday, 14 June 2019
08:00
Morning Coffee, Pastries and Networking in the Exhibit Hall
Session Title: Tox Screening and Enabling Technologies
09:00
Roger Kamm - Keynote Presentation
- 3D Microphysiological Models of Neurological Function and Disease and Their Application to Drug Screening
- Roger Kamm, Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT), United States of America
09:45
- Quantitative Assessment of Tissue Chip Technologies
- Murat Cirit, Director at Translational Center of Tissue Chip Technologies, Massachusetts Institute of Technology (MIT), United States of America
10:15
Morning Coffee Break and Networking
11:00
- Accurate Prediction of Organ-Specific Toxicities
- Daniele Zink, Principal Research Scientist and Team Leader, Institute of Bioengineering and Nanotechology, Agency for Science Technology and Research (A*STAR), Singapore
11:30
- Title to be Confirmed.
- Robert Halliwell, Professor of Neuroscience and Clinical Pharmacology, University of The Pacific, United States of America
12:00
Peter Ertl - Keynote Presentation
- Formation, Cultivation and Analysis of 3D Microtissues using a Microfluidic Multicellular Spheroid Array
- Peter Ertl, Professor of Lab-on-a-Chip Systems, Vienna University of Technology, Austria
12:45
Networking Lunch, Exhibit and Poster Viewing
13:45
Poster Awards
14:00
- Prediction of Gastrointestinal Toxicity and Drug Absorption Using the Reconstructed 3D Model of Human Small Intestine Epithelium (EpiIntestinal)
- Jan Markus, Production Manager/Senior Scientist, MatTek IVLSL, Slovak Republic
14:30
- High-Throughput Microfluidic Platform for Drug Screening of Vascularized 3D Tissues
- Sara Previdi, Scientist, University Medical Center Leiden, Netherlands
15:00
- Human Induced Pluripotent Stem (iPS) Cells in Glaucoma Modeling with an Automated Platform and 3D Retinal Organoids
- Maciej Daniszewski, Researcher, University of Melbourne, Australia
15:30
Afternoon Coffee Break and Networking
For more information about this conference visit https://www.researchandmarkets.com/research/pcx8dc/europe?w=12
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.